Accueil>>Signaling Pathways>> Tyrosine Kinase>> IGF1R>>Ganitumab

Ganitumab (Synonyms: AMG 479; Human Anti-IGF1R Recombinant Antibody)

Catalog No.GC69149

Ganitumab (AMG 479) est un anticorps monoclonal recombinant ciblant le récepteur de l'insuline de type 1 similaire à l'insuline (IGF1R) humain. Ganitumab reconnaît IGF1R murin avec une affinité subnanomolaire (KD=0,22 nM) et inhibe l'interaction entre IGF1R murin et IGF1 et IGF2. Ganitumab peut être utilisé dans la recherche sur le cancer.

Products are for research use only. Not for human use. We do not sell to patients.

Ganitumab Chemical Structure

Cas No.: 905703-97-1

Taille Prix Stock Qté
5mg
936,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Avis

Review for Ganitumab

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Ganitumab

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.